Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1 , BRCA2 , and Lynch Syndrome
American Society of Clinical Oncology Educational Book · 2024
DOI: 10.1200/edbk_433576 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Charles M Bowen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, BRCA1 Protein, BRCA2 Protein, Genetic Predisposition to Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 119 Literaturangaben.
Abstract (Originalsprache)
Germline pathogenic variants (PVs) in the BRCA1 and BRCA2 genes confer elevated risks of breast, ovarian, and other cancers. Lynch syndrome (LS) is associated with increased risks of multiple cancer types including colorectal and uterine cancers. Current cancer risk mitigation strategies have focused on pharmacologic risk reduction, enhanced surveillance, and preventive surgeries. While these approaches can be effective, they stand to be improved on because of either limited efficacy or undesirable impact on quality of life. The current review summarizes ongoing investigational efforts in cancer risk prevention strategies for patients with germline PVs in BRCA1, BRCA2, or LS-associated genes. These efforts span radiation, surgery, and pharmacology including vaccine strategies. Understanding the molecular events involved in the premalignant to malignant transformation in high-risk individuals may ultimately contribute significantly to novel prevention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Hospital of the University of Pennsylvania, Philadelphia, PA.
- Perelman Center for Advanced Medicine, Abramson Cancer Center, Philadelphia, PA.
ORCID-Profile: Payal D Shah
Zitieren
APA
Bowen, C. M., Demarest, K., Vilar, E., & Shah, P. D. (2024). Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1 , BRCA2 , and Lynch Syndrome. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_433576
Vancouver
Bowen CM, Demarest K, Vilar E, Shah PD. Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1 , BRCA2 , and Lynch Syndrome. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_433576
BibTeX
@article{Bowen2024,
author = {Bowen, Charles M and Demarest, Kaitlin and Vilar, Eduardo and Shah, Payal D},
title = {Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1 , BRCA2 , and Lynch Syndrome},
journal = {American Society of Clinical Oncology Educational Book},
year = {2024},
doi = {10.1200/edbk_433576}
}
EUVIMED